# Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2

> **NCT06560086** · NA · UNKNOWN · sponsor: **Affiliated Hospital of Nantong University** · enrollment: 10 (estimated)

## Conditions studied

- Cryptorchidism

## Interventions

- **DRUG:** Ketoconazole
- **DRUG:** Luteinizing Hormone

## Key facts

- **NCT ID:** NCT06560086
- **Lead sponsor:** Affiliated Hospital of Nantong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-03
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06560086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06560086, "Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06560086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*